Shell Asset Management Co. boosted its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 16.1% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 17,699 shares of the medical instruments supplier’s stock after buying an additional 2,450 shares during the period. Shell Asset Management Co.’s holdings in DENTSPLY SIRONA were worth $1,148,000 as of its most recent SEC filing.
Other hedge funds have also recently modified their holdings of the company. Howard Hughes Medical Institute boosted its stake in shares of DENTSPLY SIRONA by 134.9% in the first quarter. Howard Hughes Medical Institute now owns 2,751 shares of the medical instruments supplier’s stock valued at $172,000 after buying an additional 1,580 shares during the last quarter. Penserra Capital Management LLC boosted its stake in shares of DENTSPLY SIRONA by 9.5% in the first quarter. Penserra Capital Management LLC now owns 2,760 shares of the medical instruments supplier’s stock valued at $172,000 after buying an additional 240 shares during the last quarter. Howland Capital Management LLC bought a new stake in shares of DENTSPLY SIRONA during the first quarter valued at about $203,000. Gilbert & Cook Inc. bought a new stake in shares of DENTSPLY SIRONA during the second quarter valued at about $225,000. Finally, TNB Financial bought a new stake in shares of DENTSPLY SIRONA during the first quarter valued at about $259,000. Hedge funds and other institutional investors own 94.97% of the company’s stock.
DENTSPLY SIRONA Inc. (NASDAQ XRAY) opened at 61.59 on Monday. The stock’s 50 day moving average price is $63.88 and its 200-day moving average price is $62.25. The stock has a market capitalization of $14.12 billion, a PE ratio of 39.63 and a beta of 1.26. DENTSPLY SIRONA Inc. has a 12-month low of $55.00 and a 12-month high of $65.68.
DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings results on Tuesday, May 9th. The medical instruments supplier reported $0.49 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.50 by $0.01. DENTSPLY SIRONA had a return on equity of 7.37% and a net margin of 9.42%. The company had revenue of $900.50 million during the quarter, compared to analyst estimates of $916.55 million. During the same period last year, the firm earned $0.69 earnings per share. The business’s revenue was up 16.6% compared to the same quarter last year. Analysts expect that DENTSPLY SIRONA Inc. will post $2.84 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 13th. Stockholders of record on Friday, September 29th will be given a $0.0875 dividend. This represents a $0.35 dividend on an annualized basis and a dividend yield of 0.57%. The ex-dividend date is Thursday, September 28th. DENTSPLY SIRONA’s dividend payout ratio is currently 22.58%.
Several brokerages have issued reports on XRAY. BidaskClub cut DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a report on Friday, July 28th. Zacks Investment Research upgraded DENTSPLY SIRONA from a “sell” rating to a “hold” rating in a report on Wednesday, April 12th. Credit Suisse Group restated an “outperform” rating and issued a $75.00 target price (up from $67.00) on shares of DENTSPLY SIRONA in a report on Thursday, July 13th. HC Wainwright began coverage on DENTSPLY SIRONA in a report on Tuesday, July 11th. They issued a “buy” rating and a $74.00 target price for the company. Finally, Cleveland Research upgraded DENTSPLY SIRONA from a “neutral” rating to a “buy” rating in a report on Tuesday, May 23rd. Two research analysts have rated the stock with a sell rating, three have given a hold rating and nine have given a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average target price of $67.92.
About DENTSPLY SIRONA
DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY).
Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
